Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified in China as the etiologic agent of the recent COVID-19 pandemic outbreak. Due to its high transmissibility, this virus quickly spread throughout the world, causing considerable health issues. The scientific communit...
Main Authors: | Isabella Romeo, Francesco Mesiti, Antonio Lupia, Stefano Alcaro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/3/632 |
Similar Items
-
SARS-CoV-2: Virology and Drug Repurposing Approaches
by: Ratika Rahmasari, et al.
Published: (2020-07-01) -
An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
by: Omkar Indari, et al.
Published: (2021-03-01) -
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
by: Catherine Z. Chen, et al.
Published: (2021-01-01) -
Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein
by: Alfredo Juárez-Saldívar, et al.
Published: (2020-11-01) -
Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
by: Jennifer Santos, et al.
Published: (2020-06-01)